174 related articles for article (PubMed ID: 22673945)
1. Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma.
Lin M; Eng C; Hawk ET; Huang M; Lin J; Gu J; Ellis LM; Wu X
Cancer; 2012 Dec; 118(24):6188-98. PubMed ID: 22673945
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients.
Pardini B; Rosa F; Naccarati A; Vymetalkova V; Ye Y; Wu X; di Gaetano C; Buchler T; Novotny J; Matullo G; Vodicka P
Carcinogenesis; 2015 Jan; 36(1):82-6. PubMed ID: 25368035
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.
Lin M; Gu J; Eng C; Ellis LM; Hildebrandt MA; Lin J; Huang M; Calin GA; Wang D; Dubois RN; Hawk ET; Wu X
Clin Cancer Res; 2012 Jul; 18(14):3982-91. PubMed ID: 22661538
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma.
Lin M; Eng C; Hawk ET; Huang M; Greisinger AJ; Gu J; Ellis LM; Wu X; Lin J
Carcinogenesis; 2012 Apr; 33(4):841-7. PubMed ID: 22318908
[TBL] [Abstract][Full Text] [Related]
5. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
7. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
8. Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer.
Suenaga M; Cao S; Zhang W; Matsusaka S; Okazaki S; Berger MD; Miyamoto Y; Schirripa M; Barzi A; Yamamoto N; Yamaguchi T; Lenz HJ
Pharmacogenet Genomics; 2021 Jan; 31(1):10-16. PubMed ID: 32732498
[TBL] [Abstract][Full Text] [Related]
9. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
[TBL] [Abstract][Full Text] [Related]
10. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
11. Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Ning Y; Gerger A; Zhang W; Hanna DL; Yang D; Winder T; Wakatsuki T; Labonte MJ; Stintzing S; Volz N; Sunakawa Y; Stremitzer S; El-Khoueiry R; Lenz HJ
Mol Cancer Ther; 2014 Feb; 13(2):528-39. PubMed ID: 24170770
[TBL] [Abstract][Full Text] [Related]
12. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations in stem cell-related genes and colorectal cancer prognosis.
Yang H; Qu F; Myers RE; Bao G; Hyslop T; Hu G; Fei F; Xing J
J Gastrointest Cancer; 2012 Dec; 43(4):584-93. PubMed ID: 22528324
[TBL] [Abstract][Full Text] [Related]
14. Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer.
Dong G; Guo X; Fu X; Wan S; Zhou F; Myers RE; Bao G; Burkart A; Yang H; Xing J
Cancer Sci; 2012 Mar; 103(3):561-8. PubMed ID: 22182247
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in ultraconserved elements and risk of breast cancer in Chinese population.
Shen H; Lu C; Jiang Y; Tang J; Chen W; Zhang H; Zhang Q; Wang J; Liang J; Hu Z; Shen H
Breast Cancer Res Treat; 2011 Aug; 128(3):855-61. PubMed ID: 21331621
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resection.
Dai J; Wan S; Zhou F; Myers RE; Guo X; Li B; Fu X; Palazzo JP; Dou K; Yang H; Xing J
PLoS One; 2012; 7(4):e34758. PubMed ID: 22496856
[TBL] [Abstract][Full Text] [Related]
17. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738
[TBL] [Abstract][Full Text] [Related]
18. Associations between genetic polymorphisms of epidermal growth factor receptor (EGFR) and survival of colorectal cancer (CRC) patients treated with 5-fluorouracil-based chemotherapy.
Lai CY; Sung FC; Hsieh LL; Tang R; Chiou HY; Wu FY; Yeh CC
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S599-606. PubMed ID: 23800895
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of colorectal cancer-risk loci and survival outcome: A prognostic role for CDH1 variants.
Summers MG; Maughan TS; Kaplan R; Law PJ; Houlston RS; Escott-Price V; Cheadle JP
Eur J Cancer; 2020 Jan; 124():56-63. PubMed ID: 31734605
[TBL] [Abstract][Full Text] [Related]
20. Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
BMC Cancer; 2019 May; 19(1):421. PubMed ID: 31060539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]